F15063, a potential antipsychotic with dopamine D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties:: (IV) duration of brain D2-like receptor occupancy and antipsychotic-like activity versus plasma concentration in mice

被引:11
作者
Assie, Marie-Bernadette [1 ]
Bardin, Laurent [1 ]
Auclair, Agnes [1 ]
Consul-Denjean, Nathalie [1 ]
Sautel, Francois [1 ]
Depoortere, Ronan [1 ]
Newman-Tancredi, Adrian [1 ]
机构
[1] Ctr Rech Pierre Fabre, F-81106 Castres, France
关键词
antipsychotic; mouse brain; F15063; plasma levels; apomorphine-induced climbing and sniffing; D2-like receptor occupancy;
D O I
10.1007/s00210-007-0162-x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
F15063 (N-[(2,2-dimethyl-2,3-dihydro-benzofuran-7-yloxy)ethyl]-3- (cyclopent-1-enyl)-benzylamine fumarate salt) is a novel potential antipsychotic with dopamine D2/D3 blocking properties and agonist activity at 5-HT1A and D4 receptors. The pertinent parameter for pharmacological activity of antipsychotics appears to be central D2-like receptor occupancy. However, its duration is not necessarily correlated with drug plasma levels, on which clinical dosing regimens are often based. Thus, we compared in mice the duration of actions of F15063 and haloperidol to (1) inhibit apomorphine-induced climbing and sniffing (behavioural measures of D2-like receptor antagonism) and (2) occupy D2-like receptors in vivo in the striatum and olfactory tubercles (inhibition of [3H]nemonapride binding). Finally, we measured plasma levels of F15063. D2-like receptor occupancy in the striatum remained elevated at 1, 4 and 8 h postadministration, with both F15063 (ID50: 7.1, 3.6 and 16.5 mg/kg p.o., respectively) and the typical antipsychotic, haloperidol (ID50: 1.4, 0.52 and 0.53 mg/kg p.o., respectively). This was paralleled by a protracted inhibition of apomorphine-induced climbing (ED50: 0.9, 2.8 and 3.6 mg/kg p.o., and 0.21, 0.37 and 0.87 mg/kg p.o., respectively, for F15063 and haloperidol). In contrast, after administration of 10 mg/kg p.o. of F15063, its plasma levels decreased rapidly: 15.2, 2.1 and 0.6 ng/ml, 1, 4 and 8 h after administration, respectively. A similar pattern of results was observed when F15063 and haloperidol were administered i.p. and s.c., respectively. To summarise, the time-course of D2-like receptor occupancy and inhibition of apomorphine-climbing (and sniffing) behaviours was similarly long lasting with F15063 and haloperidol. In addition, the durations of action of F15063 and haloperidol in a behavioural model of antipsychotic-like activity were closely correlated to their occupancy of central D2-like receptors, and much longer than their presence in plasma. © 2007 Springer-Verlag.
引用
收藏
页码:241 / 250
页数:10
相关论文
共 34 条
[1]   Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies [J].
Abi-Dargham, A ;
Laruelle, M .
EUROPEAN PSYCHIATRY, 2005, 20 (01) :15-27
[2]   Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence [J].
Arnt, J ;
Skarsfeldt, T .
NEUROPSYCHOPHARMACOLOGY, 1998, 18 (02) :63-101
[3]   F15063, a novel antipsychotic with dopamine D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties:: III.: Duration of brain D2-like receptor occupancy, antipsychotic-like activity and plasma concentration in rodents [J].
Assie, M. B. ;
Bardin, L. ;
Auclair, A. L. ;
Consul-Denjean, N. ;
Sautel, E. ;
Kleven, M. S. ;
Depoortere, R. ;
Newman-Tancredi, A. .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 :S432-S433
[4]   In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles [J].
Assie, Marie-Bernadette ;
Dominguez, Helene ;
Consul-Denjean, Nathalie ;
Newman-Tancredi, Adrian .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 373 (06) :441-450
[5]   The 5-HT1A receptor in schizophrenia:: a promising target for novel atypical neuroleptics? [J].
Bantick, RA ;
Deakin, JFW ;
Grasby, PM .
JOURNAL OF PSYCHOPHARMACOLOGY, 2001, 15 (01) :37-46
[6]   Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties [J].
Bardin, Laurent ;
Kleven, Mark S. ;
Barret-Grevoz, Catherine ;
Depoortere, Ronan ;
Newman-Tancredi, Adrian .
NEUROPSYCHOPHARMACOLOGY, 2006, 31 (09) :1869-1879
[7]   Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? -: An in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients [J].
Bressan, RA ;
Erlandsson, K ;
Jones, HM ;
Mulligan, R ;
Flanagan, RJ ;
Ell, PJ ;
Pilowsky, LS .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (08) :1413-1420
[8]   Towards a new generation of potential antipsychotic agents combining D2 and 5-HT1A receptor activities [J].
Cuisiat, Stephane ;
Bourdiol, Nathalie ;
Lacharme, Vincent ;
Newman-Tancredi, Adrian ;
Colpaert, Francis ;
Vacher, Bernard .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (04) :865-876
[9]  
DEPOORTERE R, 2007, BR J PHARM
[10]  
FARDE L, 1992, ARCH GEN PSYCHIAT, V49, P538